Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia

Catecholaminergic polymorphic ventricular tachycardia (VT) is a lethal familial disease characterized by bidirectional VT, polymorphic VT, and ventricular fibrillation. Catecholaminergic polymorphic VT is caused by enhanced Ca2+ release through defective ryanodine receptor (RyR2) channels. We used epicardial and endocardial optical mapping, chemical subendocardial ablation with Lugol's solution, and patch clamping in a knockin (RyR2/RyR2R4496C) mouse model to investigate the arrhythmogenic mechanisms in catecholaminergic polymorphic VT. In isolated hearts, spontaneous ventricular arrhythmias occurred in 54% of 13 RyR2/RyR2R4496C and in 9% of 11 wild-type (P=0.03) littermates perfused with Ca2+and isoproterenol; 66% of 12 RyR2/RyR2R4496C and 20% of 10 wild-type hearts perfused with caffeine and epinephrine showed arrhythmias (P=0.04). Epicardial mapping showed that monomorphic VT, bidirectional VT, and polymorphic VT manifested as concentric epicardial breakthrough patterns, suggesting a focal origin in the His–Purkinje networks of either or both ventricles. Monomorphic VT was clearly unifocal, whereas bidirectional VT was bifocal. Polymorphic VT was initially multifocal but eventually became reentrant and degenerated into ventricular fibrillation. Endocardial mapping confirmed the Purkinje fiber origin of the focal arrhythmias. Chemical ablation of the right ventricular endocardial cavity with Lugol's solution induced complete right bundle branch block and converted the bidirectional VT into monomorphic VT in 4 anesthetized RyR2/RyR2R4496C mice. Under current clamp, single Purkinje cells from RyR2/RyR2R4496C mouse hearts generated delayed afterdepolarization–induced triggered activity at lower frequencies and level of adrenergic stimulation than wild-type. Overall, the data demonstrate that the His–Purkinje system is an important source of focal arrhythmias in catecholaminergic polymorphic VT.

[1]  Anna Velander Gisslén,et al.  Reference List , 2006, Mammalian Genome.

[2]  I. Efimov,et al.  Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. , 2007, Heart rhythm.

[3]  J. Anumonwo,et al.  P6-6: Inward rectifier current properties of isolated murine Purkinje cells , 2006 .

[4]  Sara Negri,et al.  Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. , 2006, Circulation research.

[5]  O. Berenfeld,et al.  Altered Right Atrial Excitation and Propagation in Connexin40 Knockout Mice , 2005, Circulation.

[6]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[7]  José Jalife,et al.  Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. , 2005, Biophysical journal.

[8]  C. Antzelevitch,et al.  Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia , 2005, Circulation.

[9]  S. Priori,et al.  Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor , 2005, Circulation research.

[10]  G. Morley,et al.  Transitions in ventricular activation revealed by two-dimensional optical mapping. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[11]  G. Bett,et al.  Computer model of action potential of mouse ventricular myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.

[12]  Heping Cheng,et al.  RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Vassalle,et al.  Calcium Overload and Cardiac Function , 2004, Journal of Biomedical Science.

[14]  A. Marks,et al.  Cardiac Ryanodine Receptor Function and Regulation in Heart Disease , 2004, Annals of the New York Academy of Sciences.

[15]  G. Bett,et al.  A model of graded calcium release and L-type Ca2+ channel inactivation in cardiac muscle. , 2004, American journal of physiology. Heart and circulatory physiology.

[16]  B. Xiao,et al.  Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (Ryanodine Receptor) Mutant Associated With Ventricular Tachycardia and Sudden Death , 2002, Circulation research.

[17]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[18]  J Jalife,et al.  Rectification of the Background Potassium Current: A Determinant of Rotor Dynamics in Ventricular Fibrillation , 2001, Circulation research.

[19]  W. Giles,et al.  A mathematical model of action potential heterogeneity in adult rat left ventricular myocytes. , 2001, Biophysical journal.

[20]  J Jalife,et al.  Visualization and functional characterization of the developing murine cardiac conduction system. , 2001, Development.

[21]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[22]  J. Jalife,et al.  High-Resolution Optical Mapping of the Right Bundle Branch in Connexin40 Knockout Mice Reveals Slow Conduction in the Specialized Conduction System , 2000, Circulation research.

[23]  M Delmar,et al.  Characterization of Conduction in the Ventricles of Normal and Heterozygous Cx43 Knockout Mice Using Optical Mapping , 1999, Journal of cardiovascular electrophysiology.

[24]  M. Janse Vulnerability to ventricular fibrillation. , 1998, Chaos.

[25]  J Jalife,et al.  Purkinje-muscle reentry as a mechanism of polymorphic ventricular arrhythmias in a 3-dimensional model of the ventricles. , 1998, Circulation research.

[26]  M. Fishbein,et al.  Effects of chemical subendocardial ablation on activation rate gradient during ventricular fibrillation. , 1995, The American journal of physiology.

[27]  P. Coumel,et al.  Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.

[28]  P. Hunter,et al.  Myocardial constitutive laws for continuum mechanics models of the heart. , 1995, Advances in experimental medicine and biology.

[29]  Peng-Sheng Chen,et al.  Effects of Subendocardial Ablation on Anodal Supernormal Excitation and Ventricular Vulnerability in Open‐Chest Dogs , 1993, Circulation.

[30]  A. Wilde,et al.  Morphology of electrophysiologically identified junctions between Purkinje fibers and ventricular muscle in rabbit and pig hearts. , 1991, Circulation research.

[31]  P. Hunter,et al.  Mathematical model of geometry and fibrous structure of the heart. , 1991, The American journal of physiology.

[32]  S. Lévy,et al.  Bidirectional Tachycardia: A New Look on the Mechanism , 1989, Pacing and clinical electrophysiology : PACE.

[33]  R. Ideker,et al.  The effect of chemical ablation of the endocardium on ventricular fibrillation threshold. , 1986, Circulation.

[34]  D. Zipes,et al.  His Bundle Electrocardiography during Bidirectional Tachycardia , 1973, Circulation.

[35]  D. Durrer,et al.  Total Excitation of the Isolated Human Heart , 1970, Circulation.

[36]  C. Lillehei,et al.  Intravital Staining of the Atrioventricular Bundle with Iodine Compounds during Cardiopulmonary Bypass , 1959, Circulation research.